GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Steris PLC (BSP:S1TE34) » Definitions » Debt-to-Equity

Steris (BSP:S1TE34) Debt-to-Equity : 0.33 (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Steris Debt-to-Equity?

Steris's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was R$917 Mil. Steris's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was R$11,766 Mil. Steris's Total Stockholders Equity for the quarter that ended in Mar. 2025 was R$38,023 Mil. Steris's debt to equity for the quarter that ended in Mar. 2025 was 0.33.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Steris's Debt-to-Equity or its related term are showing as below:

BSP:S1TE34' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.33   Med: 0.48   Max: 0.54
Current: 0.33

During the past 13 years, the highest Debt-to-Equity Ratio of Steris was 0.54. The lowest was 0.33. And the median was 0.48.

BSP:S1TE34's Debt-to-Equity is ranked worse than
59.6% of 698 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs BSP:S1TE34: 0.33

Steris Debt-to-Equity Historical Data

The historical data trend for Steris's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steris Debt-to-Equity Chart

Steris Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.50 0.54 0.54 0.33

Steris Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 0.39 0.36 0.36 0.33

Competitive Comparison of Steris's Debt-to-Equity

For the Medical Devices subindustry, Steris's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Steris's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Steris's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Steris's Debt-to-Equity falls into.


;
;

Steris Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Steris's Debt to Equity Ratio for the fiscal year that ended in Mar. 2025 is calculated as

Steris's Debt to Equity Ratio for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Steris  (BSP:S1TE34) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Steris Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Steris's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Steris Business Description

Traded in Other Exchanges
Address
5960 Heisley Road, Mentor, OH, USA, 44060
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

Steris Headlines

No Headlines